Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 4 recruiting now small index

Locked-in Syndrome clinical trials

4 of 5 indexed Locked-in Syndrome trials are currently recruiting.

Corpus placement: #3,391 of 28,707 conditions by registered trial count.

5 US clinical trials · 4 currently recruiting · #3,391 of 28,707 conditions by registered trial count

Locked-in Syndrome: 5 US clinical trials tracked, 4 recruiting.

Locked-in Syndrome is the subject of 5 registered US clinical trials on ClinicalTrials.gov, 4 of them currently open to new participants. The most active sponsor is Leigh R. Hochberg, MD, PhD., running 3 of these trials.

Enrollment posture brief

Registry condition locked-in-syndrome

OPEN 4 | RECR 80% | LATE 0 | EARLY 0 | RANK #3391 | SPON 3

Nearest open-share peer: Acute Leukemia of Ambiguous Lineage (80% recruiting · 10 trials)

Ablation80%ACL Reconstruction80%Locked-in Syndrome (this)80%Abuse, Drug60%Acceptability60%
Open-enrollment share among volume-matched conditions near Locked-in Syndrome

Locked-in Syndrome lists 4 open slots (80% of 5 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Locked-in Syndrome on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Locked-in Syndrome is recruiting above its size-band peers.

    4 of 5 indexed trials (80%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Locked-in Syndrome research.

    Leigh R. Hochberg, MD, PhD. accounts for 3 of 5 trials (60%). 3 distinct sponsors appear on at least one study for this condition label.

  3. Most Locked-in Syndrome trials plan to enrol fewer than 100 people.

    Median target enrolment is 3 among the 5 trials that report a genuine target (sentinel values excluded). 5 of those (100%) plan for fewer than 100 participants.

  4. Locked-in Syndrome research is mostly interventional.

    5 interventional and 0 observational studies make up this index (100% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase Distribution

Phase data not available

Named interventions

Most-linked intervention names on Locked-in Syndrome records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

BrainGate Neural Interface System Device
2 trials
mindBEAGLE EEG-based brain-computer interface Device
1 trials
Placement of the BrainGate2 sensor(s) into the motor-related cortex Device
1 trials
Surgical implantation of CortiCom system Device
1 trials

US sites by state

Facility locations filed on Locked-in Syndrome trials. A trial with sites in several states counts in each.

Massachusetts 3 trials
California 3 trials
Rhode Island 1 trials
Maryland 1 trials
Georgia 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Locked-in Syndrome page

5 registered trials, 4 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Locked-in Syndrome condition card totals 5 registered trials; most-linked intervention BrainGate Neural Interface System; top US site state Massachusetts. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.